Laurion Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-19,693
| Closed | -$2.07M | – | 449 |
|
|
2025
Q4 | $2.07M | Buy |
+19,693
| New | +$1.85M | 0.08% | 104 |
|
|
2025
Q3 | – | Sell |
-27,909
| Closed | -$2.3M | – | 376 |
|
|
2025
Q2 | $2.21M | Buy |
27,909
+12,069
| +76% | +$959K | 0.04% | 162 |
|
|
2025
Q1 | $1.42M | Sell |
15,840
-135,715
| -90% | -$12.7M | 0.04% | 160 |
|
|
2024
Q4 | $15.1M | Sell |
151,555
-85,224
| -36% | -$8.79M | 0.28% | 75 |
|
|
2024
Q3 | $26.9M | Buy |
+236,779
| New | +$28.1M | 0.37% | 27 |
|
|
2024
Q2 | – | Sell |
-413,847
| Closed | -$53.3M | – | 690 |
|
|
2024
Q1 | $54.6M | Buy |
413,847
+193,457
| +88% | +$23.8M | 0.46% | 47 |
|
|
2023
Q4 | $24M | Buy |
+220,390
| New | +$22.9M | 0.2% | 104 |
|
|
2023
Q3 | – | Sell |
-113,268
| Closed | -$12.2M | – | 604 |
|
|
2023
Q2 | $13.1M | Buy |
+113,268
| New | +$12.9M | 0.07% | 194 |
|
|
2022
Q2 | – | Sell |
-6,067
| Closed | -$498K | – | 624 |
|
|
2022
Q1 | $498K | Sell |
6,067
-473,301
| -99% | -$37.3M | 0.01% | 314 |
|
|
2021
Q4 | $36.7M | Sell |
479,368
-2,414,041
| -83% | -$192M | 0.37% | 48 |
|
|
2021
Q3 | $217M | Sell |
2,893,409
-766,125
| -21% | -$58.3M | 0.92% | 21 |
|
|
2021
Q2 | $285M | Buy |
3,659,534
+3,645,917
| +26,775% | +$271M | 1.58% | 11 |
|
|
2021
Q1 | $1M | Sell |
13,617
-10,038
| -42% | -$740K | 0.01% | 496 |
|
|
2020
Q4 | $1.85M | Buy |
+23,655
| New | +$1.81M | 0.01% | 350 |
|
|
2019
Q3 | – | Sell |
-1,171,564
| Closed | -$93.9M | – | 1189 |
|
|
2019
Q2 | $93.7M | Buy |
+1,171,564
| New | +$89.7M | 0.92% | 22 |
|
|
2018
Q4 | – | Sell |
-733
| Closed | -$51.7K | – | 1303 |
|
|
2018
Q3 | $50K | Sell |
733
-5,340
| -88% | -$340K | ﹤0.01% | 1114 |
|
|
2018
Q2 | $352K | Sell |
6,073
-27,629
| -82% | -$1.56M | ﹤0.01% | 1053 |
|
|
2018
Q1 | $1.75M | Sell |
33,702
-667,390
| -95% | -$36M | 0.01% | 665 |
|
|
2017
Q4 | $37.6M | Buy |
701,092
+481,166
| +219% | +$26.7M | 0.19% | 119 |
|
|
2017
Q3 | $13.4M | Buy |
219,926
+103,039
| +88% | +$6.25M | 0.06% | 249 |
|
|
2017
Q2 | $7.15M | Buy |
116,887
+15,487
| +15% | +$943K | 0.04% | 413 |
|
|
2017
Q1 | $6.15M | Buy |
101,400
+18,294
| +22% | +$1.11M | 0.05% | 383 |
|
|
2016
Q4 | $4.67M | Buy |
+83,106
| New | +$4.86M | 0.04% | 371 |
|
|
2016
Q1 | – | Sell |
-314,108
| Closed | -$15.4M | – | 974 |
|
|
2015
Q4 | $15.8M | Buy |
+314,108
| New | +$15.8M | 0.15% | 151 |
|
|
2015
Q3 | – | Sell |
-714,946
| Closed | -$38M | – | 843 |
|
|
2015
Q2 | $38.8M | Buy |
+714,946
| New | +$40.1M | 0.36% | 78 |
|
Other funds holding MRK
VCM
VPM
Laurion Capital Management's MRK Position: Q1 2026 in Review
Laurion Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 19,693 shares — an estimated $2.07M sold.
Laurion Capital Management first reported a position in MRK in Q2 2015 and held it in 25 quarters. The position peaked at $285M in Q2 2021. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Laurion Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
- Laurion Capital Management sold 19,693 Merck shares in Q1 2026, an estimated $2.07M.
- Laurion Capital Management first reported a position in Merck in Q2 2015 and held it in 25 quarters.
- Laurion Capital Management's Merck position peaked at $285M in Q2 2021.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.